Software Engineering, Treatment Planning, and QA
软件工程、治疗计划和质量保证
基本信息
- 批准号:8074387
- 负责人:
- 金额:$ 51.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-16 至
- 项目状态:未结题
- 来源:
- 关键词:AddressAlgorithmsBenchmarkingBrachytherapyClinicalClinical TrialsCodeComplexComplicationComputer softwareConduct Clinical TrialsCoupledDataData AnalysesData SetDatabasesDevelopmentDevelopment PlansDocumentationDoseEffectivenessEnsureEnvironmentEvaluationFour-dimensionalFunctional ImagingGoalsHumanImageInstitutionIntensity-Modulated RadiotherapyInterventionInvestigationLanguageLibrariesManualsMechanicsMedicalMethodologyMethodsModalityMonitorNormal tissue morphologyPathway interactionsPatientsPrincipal InvestigatorProbabilityProceduresProcessProductionProductivityProtocols documentationRadiation OncologyRadiation therapyRegimenResearchResearch InfrastructureResearch PersonnelResearch SupportResourcesSamplingSchemeSoftware EngineeringSoftware ToolsSourceSource CodeStandardizationStatistical ModelsStructureSystemTechniquesTestingTimeTranslationsUniversitiesValidationVariantVirginiaVisionWorkbaseclinical applicationdata managementdensitydesignexperiencegraphical user interfaceimage processingimage registrationimaging modalityimprovedinformation gatheringmeetingsnovelprogramsquality assurancesimulationsimulation softwaresoftware developmentstatisticstooltreatment durationtreatment planningtreatment sitetumorverification and validationvirtual
项目摘要
The overall goal of Core A is to develop a unique and enhanced software engineering, IMRT planning and
quality assurance infrastructure, that addresses the unique data management needs, error pathways, and
logistical constraints posed by image guided adaptive radiation therapy (IGART). IGART confronts radiation
oncology with new and unfamiliar demands: a high volume of imaging data drawn from many different
modalities, new clinical tools such as deformable image registration which must perform reliably in a real-
time automated mode, the need for real-time IMRT planning codes that deliver optimal plans with little or no
intervention, and integration of complex software tools and functions drawn from the other projects and cores
into an integrated structure. These functions include the comprehensive management and manipulation of
multiple imaging data sets from diverse imaging modalities, IGART IMRT planning incorporating probabilistic
models, maintaining a plan database, and acquiring statistics derived from the quantitative plan evaluation
tools such as equivalent uniform dose (EUD), normal tissue complication probability (NTCP), tumor control
probability (TCP), and biologically equivalent dose (BED) to accommodate variations in fraction size and to
allow summation of brachytherapy and external beam dose distributions. Core A will provide the following
functions to meet the overall goals of this PPG of which develops, investigates, optimizes, and implements a
system to study the potential clinical advantages of IGART via coupled virtual clinical trials (VCTs) and
clinical trials (ACTs). Core Function 1 will develop a novel layered software engineering and data
management infrastructure, based upon a shared set of user-program data structures, common tools, and
simulation scripting languages, that isolates software developers from the mechanics of storing and
retrieving data and converting imaging studies from a variety of native formats to a common format for
performing virtual clinical trials (VCTs) conducted by Projects 1-4. Core Function 2 will interface new tools
as they are developed in Projects 1-4 into the software infrastructure, which will form the VCD IGART
system. Core Function 3 will generate automated IMRT re-optimizations and treatment plans, and data
analysis utilizing the VCU IGART system. Core Function 4 will focus on developing a comprehensive set of
QA tools and techniques to facilitate the safe and efficient clinical implementation of IGART.
核心 A 的总体目标是开发独特且增强的软件工程、IMRT 规划和
质量保证基础设施,解决独特的数据管理需求、错误路径和
图像引导适应性放射治疗(IGART)带来的后勤限制。 IGART 对抗辐射
肿瘤学具有新的和不熟悉的需求:从许多不同的领域提取的大量成像数据
模式,新的临床工具,例如变形图像配准,必须在真实的环境中可靠地执行
时间自动化模式,需要实时 IMRT 计划代码,以很少或根本不需要提供最佳计划
干预以及集成来自其他项目和核心的复杂软件工具和功能
成一个一体化的结构。这些功能包括综合管理和操纵
来自不同成像模式的多个成像数据集,IGART IMRT 规划结合概率
模型、维护计划数据库并获取从定量计划评估中得出的统计数据
等效均匀剂量 (EUD)、正常组织并发症概率 (NTCP)、肿瘤控制等工具
概率(TCP)和生物等效剂量(BED)以适应分数大小的变化并
允许近距离放射治疗和外束剂量分布的求和。核心A将提供以下内容
旨在实现本 PPG 的总体目标,其中开发、调查、优化和实施
通过耦合虚拟临床试验(VCT)研究 IGART 潜在临床优势的系统
临床试验(ACT)。核心功能 1 将开发一种新颖的分层软件工程和数据
管理基础设施,基于一组共享的用户程序数据结构、通用工具和
模拟脚本语言,将软件开发人员与存储和存储机制隔离开来
检索数据并将成像研究从各种本机格式转换为通用格式
执行项目 1-4 进行的虚拟临床试验 (VCT)。核心功能 2 将连接新工具
因为它们在项目 1-4 中被开发成软件基础设施,这将形成 VCD IGART
系统。核心功能 3 将生成自动 IMRT 重新优化和治疗计划以及数据
利用 VCU IGART 系统进行分析。核心功能 4 将重点开发一套全面的
促进 IGART 安全高效临床实施的 QA 工具和技术。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEFFREY F WILLIAMSON其他文献
JEFFREY F WILLIAMSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEFFREY F WILLIAMSON', 18)}}的其他基金
Quantitative dual-energy CT imaging for radiation therapy treatment planning
用于放射治疗计划的定量双能 CT 成像
- 批准号:
8105671 - 财政年份:2011
- 资助金额:
$ 51.73万 - 项目类别:
Quantitative dual-energy CT imaging for radiation therapy treatment planning
用于放射治疗计划的定量双能 CT 成像
- 批准号:
8444300 - 财政年份:2011
- 资助金额:
$ 51.73万 - 项目类别:
Quantitative dual-energy CT imaging for radiation therapy treatment planning
用于放射治疗计划的定量双能 CT 成像
- 批准号:
8628785 - 财政年份:2011
- 资助金额:
$ 51.73万 - 项目类别:
Biostatistics, Outcomes Modeling, Clinical Design, and Administration
生物统计学、结果建模、临床设计和管理
- 批准号:
7806516 - 财政年份:2007
- 资助金额:
$ 51.73万 - 项目类别:
Image-guided IMRT and Brachytherapy for Pelvic Tumors
图像引导 IMRT 和近距离放射治疗盆腔肿瘤
- 批准号:
8074385 - 财政年份:2007
- 资助金额:
$ 51.73万 - 项目类别:
Image-guided IMRT and Brachytherapy for Pelvic Tumors
图像引导 IMRT 和近距离放射治疗盆腔肿瘤
- 批准号:
8256663 - 财政年份:2007
- 资助金额:
$ 51.73万 - 项目类别:
Software Engineering, Treatment Planning, and QA
软件工程、治疗计划和质量保证
- 批准号:
7806515 - 财政年份:2007
- 资助金额:
$ 51.73万 - 项目类别:
Image-guided IMRT and Brachytherapy for Pelvic Tumors
图像引导 IMRT 和近距离放射治疗盆腔肿瘤
- 批准号:
7806513 - 财政年份:2007
- 资助金额:
$ 51.73万 - 项目类别:
Biostatistics, Outcomes Modeling, Clinical Design, and Administration
生物统计学、结果建模、临床设计和管理
- 批准号:
8074388 - 财政年份:2007
- 资助金额:
$ 51.73万 - 项目类别:
Biostatistics, Outcomes Modeling, Clinical Design, and Administration
生物统计学、结果建模、临床设计和管理
- 批准号:
8256666 - 财政年份:2007
- 资助金额:
$ 51.73万 - 项目类别:
相似国自然基金
随机阻尼波动方程的高效保结构算法研究
- 批准号:12301518
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
大规模黎曼流形稀疏优化算法及应用
- 批准号:12371306
- 批准年份:2023
- 资助金额:43.5 万元
- 项目类别:面上项目
基于任意精度计算架构的量子信息处理算法硬件加速技术研究
- 批准号:62304037
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
分布式非凸非光滑优化问题的凸松弛及高低阶加速算法研究
- 批准号:12371308
- 批准年份:2023
- 资助金额:43.5 万元
- 项目类别:面上项目
基于物理信息神经网络的雷达回波资料反演蒸发波导算法研究
- 批准号:42305048
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Combining Machine Learning and Nanofluidic Technology for The Multiplexed Diagnosis of Pancreatic Adenocarcinoma
结合机器学习和纳流体技术进行胰腺癌的多重诊断
- 批准号:
10613226 - 财政年份:2023
- 资助金额:
$ 51.73万 - 项目类别:
Learn Systems Biology Equations From Snapshot Single Cell Genomic Data
从快照单细胞基因组数据学习系统生物学方程
- 批准号:
10736507 - 财政年份:2023
- 资助金额:
$ 51.73万 - 项目类别:
Imaging and multi-omics analyses to identify molecular subtypes of distinct emphysema patterns
影像学和多组学分析可识别不同肺气肿模式的分子亚型
- 批准号:
10736162 - 财政年份:2023
- 资助金额:
$ 51.73万 - 项目类别:
Software for stent failure prevention using intravascular OCT images
使用血管内 OCT 图像预防支架失效的软件
- 批准号:
10685081 - 财政年份:2023
- 资助金额:
$ 51.73万 - 项目类别:
Development of an Efficient High Throughput Technique for the Identification of High-Impact Non-Coding Somatic Variants Across Multiple Tissue Types
开发一种高效的高通量技术,用于鉴定跨多种组织类型的高影响力非编码体细胞变异
- 批准号:
10662860 - 财政年份:2023
- 资助金额:
$ 51.73万 - 项目类别: